Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGRL Aguia Resources	C$0.13 -7.1%	C$0.13	C$0.08 ▼ C$0.18	C$24.14M	N/A	418,301 shs	361,698 shs
ASND Ascendis Pharma A/S	$142.17 +0.5%	$149.17	$66.03 ▼ $161.00	$8.28B	0.5	376,840 shs	299,396 shs
KZD Kaizen Discovery	C$0.09 -5.6%	C$0.08	C$0.08 ▼ C$0.21	C$5.61M	1.38	11,790 shs	1,000 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGRL Aguia Resources	0.00%	0.00%	0.00%	0.00%	0.00%
ASND Ascendis Pharma A/S	+0.47%	-6.82%	-3.33%	+6.91%	+74.91%
KZD Kaizen Discovery	0.00%	0.00%	0.00%	0.00%	-29.17%

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AGRL Aguia Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	1.5629 of 5 stars	3.4	1.0	0.0	0.0	2.7	1.7	0.6
KZD Kaizen Discovery	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGRL Aguia Resources	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	2.88	Moderate Buy	$173.25	21.86% Upside
KZD Kaizen Discovery	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest ASND, VML, MRP, AGRL, and KZD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/2/2024	ASND Ascendis Pharma A/S	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$165.00 ➝ $167.00
4/1/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$173.00
3/15/2024	ASND Ascendis Pharma A/S	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$196.00 ➝ $260.00
2/8/2024	ASND Ascendis Pharma A/S	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$146.00 ➝ $182.00
2/8/2024	ASND Ascendis Pharma A/S	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$207.00 ➝ $225.00
2/6/2024	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$152.00 ➝ $173.00

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGRL Aguia Resources	C$-8.39K	-2,877.23	C$0.01 per share	14.00	C$0.19 per share	0.69
ASND Ascendis Pharma A/S	$288.08M	28.73	N/A	N/A	($2.73) per share	-52.08
KZD Kaizen Discovery	N/A	N/A	C$0.01 per share	6.04	C$0.04 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGRL Aguia Resources	N/A	-C$0.01	N/A	∞	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	-$521.07M	-$9.25	N/A	N/A	N/A	-180.61%	-16,574.15%	-55.10%	4/25/2024 (Estimated)
KZD Kaizen Discovery	-C$2.23M	-C$0.03	N/A	∞	N/A	N/A	-67.62%	-47.47%	N/A

Latest ASND, VML, MRP, AGRL, and KZD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/7/2024	Q4 2023	ASND Ascendis Pharma A/S	-$2.15	-$1.66	+$0.49	-$1.66	$97.02 million	$148.62 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGRL Aguia Resources	N/A	N/A	N/A	N/A	N/A
ASND Ascendis Pharma A/S	N/A	N/A	N/A	N/A	N/A
KZD Kaizen Discovery	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGRL Aguia Resources	N/A	1.61	1.48
ASND Ascendis Pharma A/S	N/A	3.56	2.50
KZD Kaizen Discovery	66.28	0.35	1.96

Ownership

Institutional Ownership

Company	Institutional Ownership
AGRL Aguia Resources	N/A
ASND Ascendis Pharma A/S	N/A
KZD Kaizen Discovery	1.21%

Insider Ownership

Company	Insider Ownership
AGRL Aguia Resources	N/A
ASND Ascendis Pharma A/S	40.00%
KZD Kaizen Discovery	82.72%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AGRL Aguia Resources	N/A	185.67 million	N/A	Not Optionable
ASND Ascendis Pharma A/S	879	58.22 million	34.93 million	Optionable
KZD Kaizen Discovery	N/A	65.94 million	N/A	Not Optionable

ASND, VML, MRP, AGRL, and KZD Headlines

Source	Headline
	All Grand Kaizen Codes (April 2024) escapistmagazine.com - April 16 at 12:24 AM
	Kaizen Codes (April 2024) escapistmagazine.com - April 8 at 8:04 PM
	Kinderhook scoops up collision repair chain Kaizen Auto Care pehub.com - March 18 at 9:19 AM
	Kaizen Codes (March 2024) twinfinite.net - March 9 at 8:21 PM
	IE Mar 2024 10.000 put finance.yahoo.com - February 17 at 1:27 AM
	Ivanhoe Electric to acquire remaining interest in Peru-focused Kaizen Discovery mining.com - December 4 at 1:10 PM
	Kaizen Discovery Signs Share Purchase Agreement to Sell the Coppermine Project to Durango Gold Corp. finance.yahoo.com - November 29 at 12:48 AM
	Kaizen codes (November 2023) dotesports.com - November 22 at 2:15 PM
	Kaizen Discovery Signs Share Purchase Agreement to Sell the Aspen Grove and Tanzilla Projects to Pinwheel Resources Ltd. finance.yahoo.com - November 16 at 7:01 PM
	Kaizen Discovery Inc KZD morningstar.com - November 11 at 12:51 AM
	Grim discovery: Human skull found inside Florida thrift store foxnews.com - November 9 at 5:27 PM
	Kaizen Tavern Replaced With New Concept In Del Ray msn.com - October 11 at 12:48 PM
	Kaizen Agro Infrabuild share price livemint.com - October 6 at 7:57 PM
	2024 Land Rover Discovery driving.ca - October 6 at 2:53 PM
	KERA and Kaizen Development Partners announce development partnership, including new KERA headquarters kera.org - September 28 at 6:29 PM
	Kaizen Development Partners, KERA, teaming up for new high-rise project in Dallas bizjournals.com - September 28 at 6:29 PM
	Kaizen Institute Partners with ALICE Technologies to Bring Construction Optioneering to Global Clients constructiondive.com - September 13 at 6:58 PM
	Closing Bell: Kaizen Discovery Inc down on Thursday (KZD) theglobeandmail.com - August 29 at 4:55 AM
	Closing Bell: Kaizen Discovery Inc up on Friday (KZD) theglobeandmail.com - August 24 at 2:54 AM
	For the 2nd Time, Kaizen Health Makes the Inc. 5000, at No. 662 in 2023 benzinga.com - August 16 at 4:37 PM
	SME Foundation supports 62 orgs, 390 entrepreneurs in implementing 'Kaizen' tbsnews.net - July 31 at 3:14 PM
	Behavior Science Explains Why the Japanese Practice of Kaizen, or Continuous Improvement, Accelerates Your Success inc.com - July 29 at 5:44 AM
	What Is Kaizen, how it help overcome laziness and grow in your personal life? msn.com - July 22 at 9:50 AM
	Kaizen Discovery Inc.: Kaizen Discovery Arranges C$2 Million Short-Term Loan from Ivanhoe Electric finanznachrichten.de - June 30 at 12:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aguia Resources

CVE:AGRL

Aguia Resources Limited engages in the exploration and development of mineral resource projects in Brazil. Its flagship Rio Grande phosphate assets include the Três Estradas, Joca Tavares, Porteira carbonatite, and Cerro Preto deposits located in the state of Rio Grande do Sul in southern Brazil. Aguia Resources Limited was incorporated in 2007 and is based in Belo Horizonte, Brazil.

Ascendis Pharma A/S

NASDAQ:ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Kaizen Discovery

CVE:KZD

Kaizen Discovery Inc. engages in the exploration of mineral projects in Peru and Canada. It holds interest in the Pinaya Copper-Gold Project that covers an area of 101 square kilometers and includes 10 kilometers of underexplored strike length within the Andahuaylas-Yauri Porphyry Belt in southeastern Peru. The company is headquartered in Vancouver, Canada. As of February 6, 2024, Kaizen Discovery Inc. operates as a subsidiary of Ivanhoe Electric Inc.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial